Clinical trial
A Non-randomized Trial of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Outside of the United States
NCT03807531 is registered in ClinicalTrials.gov with ReFlow Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-randomized Trial of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Outside of the United States
- Lead sponsor
- ReFlow Medical, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 11, 2019
- Completion date
- June 1, 2027
- Enrollment
- 100 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.